AI CAPITAL INTELLIGENCE
德睿智药 funding history
1 recorded financing disclosures for 德睿智药. Dates, rounds, currencies and original sources follow the individual records. This is not a complete company funding history.
Latest recorded funding, at a glance
The latest disclosure recorded for 德睿智药 is dated 2026-07-08: Series B, USD 52,000,000. Named investors: Not disclosed. This is the latest record in our coverage, not a claim about all company financing.
Verify this disclosure · Original source 1 · Original source 2 · Original source 3 · Original source 4 · Original source 5 · Original source 6 · Original source 7
Disclosures and evidence
| Disclosure date | Round | Disclosed amount | Named investors | Evidence |
|---|---|---|---|---|
| Series B | USD 52,000,000 | Not disclosed | Record · Source 1 · Source 2 · Source 3 · Source 4 · Source 5 · Source 6 · Source 7 |
Recorded financing disclosures
- 德睿智药2026-07-08 · Series B · USD 52,000,000
Publicly disclosed founding team
- 牛张明 (Chinese) · 创始人兼CEO